No Difference in Markers of Adipose Tissue Inflammation Between Overweight Women with Polycystic Ovary Syndrome and Weight-matched Controls

Overview

Journal Hum Reprod

Publisher Oxford University Press

Specialty Reproductive Medicine

Date 2011 Apr 12

PMID 21478181

Citations 16

Authors

Asa Lindholm

Caroline Blomquist

Marie Bixo

Ingrid Dahlbom

Tony Hansson

Inger Sundstrom Poromaa

Jonas Buren

Affiliations

Soon will be listed here.

Abstract

Unlabelled: BACKGROUND; Previous studies have indicated that peripheral circulating markers of inflammation are elevated in women with polycystic ovary syndrome (PCOS), but thus far no studies concerning markers of inflammation in adipose tissue have been published. The aim of the study was to investigate whether patients with PCOS display increased expression of inflammatory markers in adipose tissue.

Methods: Twenty overweight patients with PCOS, 10 lean patients with PCOS and 20 overweight controls had subcutaneous fat biopsies and blood samples taken. Adipose tissue levels of mRNA of inflammatory markers were determined by use of real-time PCR.

Results: Overweight patients with PCOS had higher relative adipose tissue chemokine ligand 2 (P < 0.01), and its cognate receptor (P < 0.05), tumour necrosis factor-α (P < 0.001), interleukin (IL)-10 (P < 0.001) and IL-18 (P < 0.001) and the monocyte/macrophage markers CD14 (P < 0.01) and CD163 (P < 0.01) mRNA levels compared with lean women with PCOS. There were no differences between overweight patients with PCOS and overweight control subjects in this respect. Within the PCOS group, markers of adipose tissue inflammation correlated significantly with obesity-related metabolic disturbances, but when data were adjusted for age and BMI, most correlations were lost.

Conclusions: Overweight, rather than the PCOS diagnosis per se, appears to be the main explanatory variable for elevated adipose tissue inflammation in patients with PCOS.

Citing Articles

Mechanisms and Target Parameters in Relation to Polycystic Ovary Syndrome and Physical Exercise: Focus on the Master Triad of Hormonal Changes, Oxidative Stress, and Inflammation.

Lorincz C, Borzsei D, Hoffmann A, Varga C, Szabo R Biomedicines. 2024; 12(3).

PMID: 38540173 PMC: 10968456. DOI: 10.3390/biomedicines12030560.

Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic....

Yousuf S, Ganie M, Urwat U, Andrabi S, Zargar M, Dar M BMC Womens Health. 2023; 23(1):68.

PMID: 36793022 PMC: 9933286. DOI: 10.1186/s12905-023-02187-5.

Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome.

Kabakchieva P, Gateva A, Velikova T, Georgiev T, Yamanishi K, Okamura H Arch Endocrinol Metab. 2022; 66(1):3-11.

PMID: 35263047 PMC: 9991028. DOI: 10.20945/2359-3997000000442.

The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.

Aboeldalyl S, James C, Seyam E, Ibrahim E, Shawki H, Amer S Int J Mol Sci. 2021; 22(5).

PMID: 33800490 PMC: 7962967. DOI: 10.3390/ijms22052734.

Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?.

Moin A, Sathyapalan T, Butler A, Atkin S Front Endocrinol (Lausanne). 2021; 12:638621.

PMID: 33716989 PMC: 7947877. DOI: 10.3389/fendo.2021.638621.

References

Dahlman I, Kaaman M, Olsson T, Tan G, Bickerton A, Wahlen K . A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab. 2005; 90(10):5834-40. DOI: 10.1210/jc.2005-0369. View

Bautista L, Vera L, Arenas I, Gamarra G . Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2004; 19(2):149-54. DOI: 10.1038/sj.jhh.1001785. View

Sowers M, Jannausch M, Randolph J, McConnell D, Little R, Lasley B . Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. J Clin Endocrinol Metab. 2005; 90(11):6064-71. DOI: 10.1210/jc.2005-0765. View

Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb H . Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology. 2004; 146(3):1006-11. DOI: 10.1210/en.2004-0924. View

Dietze-Schroeder D, Sell H, Uhlig M, Koenen M, Eckel J . Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes. 2005; 54(7):2003-11. DOI: 10.2337/diabetes.54.7.2003. View

Despres J, Lemieux I . Abdominal obesity and metabolic syndrome. Nature. 2006; 444(7121):881-7. DOI: 10.1038/nature05488. View

Spranger J, Kroke A, Mohlig M, Bergmann M, Ristow M, Boeing H . Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003; 361(9353):226-8. DOI: 10.1016/S0140-6736(03)12255-6. View

Hotamisligil G, Arner P, Caro J, Atkinson R, Spiegelman B . Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995; 95(5):2409-15. PMC: 295872. DOI: 10.1172/JCI117936. View

Murdolo G, Hammarstedt A, Sandqvist M, Schmelz M, Herder C, Smith U . Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin. J Clin Endocrinol Metab. 2007; 92(7):2688-95. DOI: 10.1210/jc.2006-2814. View

10.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

11.

Barber T, Golding S, Alvey C, Wass J, Karpe F, Franks S . Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007; 93(3):999-1004. DOI: 10.1210/jc.2007-2117. View

12.

Cancello R, Clement K . Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG. 2006; 113(10):1141-7. DOI: 10.1111/j.1471-0528.2006.01004.x. View

13.

Holte J, Bergh T, Berne C, Berglund L, Lithell H . Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994; 78(5):1052-8. DOI: 10.1210/jcem.78.5.8175959. View

14.

Yildirim B, Sabir N, Kaleli B . Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003; 79(6):1358-64. DOI: 10.1016/s0015-0282(03)00265-6. View

15.

Andersen C, Jensen J, Orntoft T . Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64(15):5245-50. DOI: 10.1158/0008-5472.CAN-04-0496. View

16.

Ajuwon K, Spurlock M . Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol. 2004; 288(5):R1220-5. DOI: 10.1152/ajpregu.00397.2004. View

17.

Olszanecka-Glinianowicz M, Banas M, Zahorska-Markiewicz B, Janowska J, Kocelak P, Madej P . Is the polycystic ovary syndrome associated with chronic inflammation per se?. Eur J Obstet Gynecol Reprod Biol. 2007; 133(2):197-202. DOI: 10.1016/j.ejogrb.2006.10.037. View

18.

Lettesjo H, Hansson T, Bergqvist A, Gronlund J, Dannaeus A . Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease. Clin Exp Immunol. 2004; 139(1):138-43. PMC: 1809275. DOI: 10.1111/j.1365-2249.2005.02661.x. View

19.

Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E . Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab. 2007; 92(6):2240-7. DOI: 10.1210/jc.2006-1811. View

20.

Knochenhauer E, Key T, Kahsar-Miller M, Waggoner W, Boots L, Azziz R . Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998; 83(9):3078-82. DOI: 10.1210/jcem.83.9.5090. View